What This Desk Is

What Pure Amino Peptides is

Pure Amino Peptides is an independent research digest focused on the chemistry and published science of synthetic research peptides. The frame here is structural: we read peptides through their amino-acid sequences, their molecular targets, and what the literature has actually established — before we read them through the marketing claims that often arrive first.

This desk covers three compounds — GHK-Cu, BPC-157, and Ipamorelin — chosen because they represent three distinct structural classes and three very different evidence profiles. GHK-Cu is a minimalist copper-chelated tripeptide with real, controlled topical human data. BPC-157 is a proline-stabilized 15-mer with an enormous animal record and almost no human trials. Ipamorelin is a fully synthetic pentapeptide built from non-natural amino acids, with a well-characterized human pharmacokinetic profile and a Phase 2 trial that failed.

We do not sell any products. We do not promote vendors or suppliers. We have no commercial relationship with any peptide company. We do not give medical advice and we do not list or imply human doses. The aim is a factual, cited reference that lets a reader understand what each peptide is chemically, what the research has shown, and where the evidence ends.

Editorial method and citation standards

Every factual claim on this site is drawn from a peer-reviewed study, regulatory document, or established pharmacopeia source. References are cited by number throughout — for example ^[11] — and every source is listed on the references page with the full citation, journal, year, DOI (where available), and a PubMed or equivalent link.

Where the evidence is thin, we say so. Where a finding is from rats and not from humans, we say so. Where a large share of the foundational literature comes from a single research group (as it does for BPC-157 and for GHK-Cu's gene-expression work), we note that and what it means for independent replication. We treat the absence of human data as informative, not as something to paper over with mechanism extrapolation.

We distinguish between clinical findings (from controlled human trials), preclinical findings (from animal or cell models), mechanistic arguments (plausible from known biology but not directly tested), and anecdotal community reports (personal accounts from research-use communities, clearly labeled as such). These are different kinds of evidence and should not be blended.

This site does not offer a second opinion on medical decisions and is not a substitute for consultation with a qualified clinician.

Independence and disclaimer

Pure Amino Peptides is an independent editorial publication. It has no affiliation with any pharmaceutical company, peptide supplier, research-chemical vendor, or clinical practice. No content on this site constitutes medical advice, diagnosis, or treatment. The compounds described here are research chemicals — not approved drugs for human use (with the limited exception of GHK-Cu as a cosmetic ingredient in topical products). Their safety, efficacy, and long-term effects in people are, to varying degrees, unestablished.

Two of the three compounds covered here are prohibited in competitive sport by the World Anti-Doping Agency (BPC-157 under S0; Ipamorelin under S2). Any person subject to anti-doping rules should consult the current WADA Prohibited List and their national anti-doping organization before any engagement with these compounds in a research context.

All content is for educational and informational purposes only.